Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

50.29
+0.28000.56%
Post-market: 50.290.00000.00%16:15 EDT
Volume:2.81M
Turnover:141.29M
Market Cap:101.72B
PE:16.08
High:50.71
Open:50.19
Low:50.06
Close:50.01
52wk High:61.70
52wk Low:39.29
Shares:2.02B
Float Shares:1.94B
Volume Ratio:1.12
T/O Rate:0.14%
Dividend:1.82
Dividend Rate:3.62%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.31
PE(LYR):13.46

Loading ...

GSK Gets Japan Approval for Prefilled Shingrix Syringe

MT Newswires Live
·
Sep 10

GSK Has Limited Margin for Error to Hit 2031 Target

Dow Jones
·
Sep 09

RBC Capital downgrades GlaxoSmithKline (GSK) to a Hold

TIPRANKS
·
Sep 09

Market Chatter: GSK to Raise $6.5 Billion From US Debt Sale to Fund Nuvalent Acquisition

MT Newswires Live
·
Sep 09

GSK to Raise $6.5 Billion From US Debt Sale to Fund Nuvalent Acquisition, Bloomberg Reports

MT Newswires Live
·
Sep 09

GSK Slips Tuesday, Underperforms Market

Dow Jones
·
Sep 09

GSK Launches Six-Part Dollar Bond Sale to Support Nuvalent Acquisition Financing, Bloomberg Reports

MT Newswires Live
·
Sep 08

Barclays Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 08

GSK Slides Friday, Underperforms Market

Dow Jones
·
Sep 05

Adlai Nortye's KRAS Opportunity Further Validated by GSK-Hutchmed Deal, Oppenheimer Says

MT Newswires Live
·
Sep 04

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live
·
Sep 04

Deutsche Bank Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Barclays Keeps Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 01

GSK Advances Early-Stage Lung Drug With New Formulation Study

TIPRANKS
·
Aug 28

GSK Slips Thursday, Underperforms Market

Dow Jones
·
Aug 28

GSK’s Pediatric Asthma Trial Signals Long-Term Upside in Biologic Market

TIPRANKS
·
Aug 27

GSK Names Tina Graves President, General Manager for Canada

Reuters
·
Aug 26

GSK price target raised to 1,900 GBp from 1,750 GBp at Morgan Stanley

TIPRANKS
·
Aug 26

Morgan Stanley Keeps Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Aug 25